Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 51

1.

Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases.

Di Giovanni G, Svob Strac D, Sole M, Unzeta M, Tipton KF, Mück-Šeler D, Bolea I, Della Corte L, Nikolac Perkovic M, Pivac N, Smolders IJ, Stasiak A, Fogel WA, De Deurwaerdère P.

Front Neurosci. 2016 Nov 24;10:541. eCollection 2016. Review.

2.

Ontogeny of Norepinephrine Transporter Expression and Antidepressant-Like Response to Desipramine in Wild-Type and Serotonin Transporter Mutant Mice.

Mitchell NC, Bowman MA, Gould GG, Koek W, Daws LC.

J Pharmacol Exp Ther. 2017 Jan;360(1):84-94. Epub 2016 Nov 9.

PMID:
27831486
3.

Corticosterone Potentiation of Cocaine-Induced Reinstatement of Conditioned Place Preference in Mice is Mediated by Blockade of the Organic Cation Transporter 3.

McReynolds JR, Taylor A, Vranjkovic O, Ambrosius T, Derricks O, Nino B, Kurtoglu B, Wheeler RA, Baker DA, Gasser PJ, Mantsch JR.

Neuropsychopharmacology. 2017 Feb;42(3):757-765. doi: 10.1038/npp.2016.187. Epub 2016 Sep 8.

PMID:
27604564
4.

The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition.

Wang J.

Clin Pharmacol Ther. 2016 Nov;100(5):489-499. doi: 10.1002/cpt.442. Epub 2016 Sep 19. Review.

PMID:
27506881
5.

Transendothelial Transport and Its Role in Therapeutics.

Upadhyay RK.

Int Sch Res Notices. 2014 Aug 27;2014:309404. doi: 10.1155/2014/309404. eCollection 2014. Review.

6.

SSRI Augmentation by 5-Hydroxytryptophan Slow Release: Mouse Pharmacodynamic Proof of Concept.

Jacobsen JP, Rudder ML, Roberts W, Royer EL, Robinson TJ, Oh A, Spasojevic I, Sachs BD, Caron MG.

Neuropsychopharmacology. 2016 Aug;41(9):2324-34. doi: 10.1038/npp.2016.35. Epub 2016 Mar 2.

7.

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease.

Buddhala C, Loftin SK, Kuley BM, Cairns NJ, Campbell MC, Perlmutter JS, Kotzbauer PT.

Ann Clin Transl Neurol. 2015 Oct;2(10):949-59. doi: 10.1002/acn3.246. Epub 2015 Sep 12.

8.

Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue.

Ayala-Lopez N, Jackson WF, Burnett R, Wilson JN, Thompson JM, Watts SW.

Am J Physiol Heart Circ Physiol. 2015 Dec 1;309(11):H1904-14. doi: 10.1152/ajpheart.00308.2015. Epub 2015 Oct 2.

9.

Sex-related differences in small intestinal transit and serotonin dynamics in high-fat-diet-induced obesity in mice.

France M, Skorich E, Kadrofske M, Swain GM, Galligan JJ.

Exp Physiol. 2016 Jan;101(1):81-99. doi: 10.1113/EP085427. Epub 2015 Oct 28.

10.

Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors.

Duan H, Hu T, Foti RS, Pan Y, Swaan PW, Wang J.

Drug Metab Dispos. 2015 Nov;43(11):1773-80. doi: 10.1124/dmd.115.064824. Epub 2015 Aug 18.

11.

An immunohistochemical analysis of SERT in the blood-brain barrier of the male rat brain.

Young LW, Darios ES, Watts SW.

Histochem Cell Biol. 2015 Oct;144(4):321-9. doi: 10.1007/s00418-015-1343-1. Epub 2015 Jul 31.

13.

Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene.

Adamsen D, Ramaekers V, Ho HT, Britschgi C, Rüfenacht V, Meili D, Bobrowski E, Philippe P, Nava C, Van Maldergem L, Bruggmann R, Walitza S, Wang J, Grünblatt E, Thöny B.

Mol Autism. 2014 Aug 13;5:43. doi: 10.1186/2040-2392-5-43. eCollection 2014.

14.

Pet-1 Controls Tetrahydrobiopterin Pathway and Slc22a3 Transporter Genes in Serotonin Neurons.

Wyler SC, Donovan LJ, Yeager M, Deneris E.

ACS Chem Neurosci. 2015 Jul 15;6(7):1198-205. doi: 10.1021/cn500331z. Epub 2015 Feb 18.

15.

5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.

Martin CB, Martin VS, Trigo JM, Chevarin C, Maldonado R, Fink LH, Cunningham KA, Hamon M, Lanfumey L, Mongeau R.

Int J Neuropsychopharmacol. 2014 Oct 31;18(3). pii: pyu056. doi: 10.1093/ijnp/pyu056.

16.

Serotonin in the ventral hippocampus modulates anxiety-like behavior during amphetamine withdrawal.

Tu W, Cook A, Scholl JL, Mears M, Watt MJ, Renner KJ, Forster GL.

Neuroscience. 2014 Dec 5;281:35-43. doi: 10.1016/j.neuroscience.2014.09.019. Epub 2014 Sep 18.

17.

Serotonin and sensory nerves: meeting in the cardiovascular system.

Watts SW.

Vascul Pharmacol. 2014 Oct;63(1):1-3. doi: 10.1016/j.vph.2014.08.003. Epub 2014 Aug 30. Review.

18.

Drosophila melanogaster as a genetic model system to study neurotransmitter transporters.

Martin CA, Krantz DE.

Neurochem Int. 2014 Jul;73:71-88. doi: 10.1016/j.neuint.2014.03.015. Epub 2014 Apr 3. Review.

19.

Diet-induced changes in the Lean Brain: Hypercaloric high-fat-high-sugar snacking decreases serotonin transporters in the human hypothalamic region.

Koopman KE, Booij J, Fliers E, Serlie MJ, la Fleur SE.

Mol Metab. 2013 Aug 7;2(4):417-22. doi: 10.1016/j.molmet.2013.07.006. eCollection 2013.

20.

5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice.

Montañez S, Munn JL, Owens WA, Horton RE, Daws LC.

Neurochem Int. 2014 Jul;73:127-31. doi: 10.1016/j.neuint.2013.11.004. Epub 2013 Nov 15.

Supplemental Content

Support Center